IL165763A0 - Process for preparing 5-(1,3-oxazol-2-yl)benzoic acid derivatives - Google Patents

Process for preparing 5-(1,3-oxazol-2-yl)benzoic acid derivatives

Info

Publication number
IL165763A0
IL165763A0 IL16576304A IL16576304A IL165763A0 IL 165763 A0 IL165763 A0 IL 165763A0 IL 16576304 A IL16576304 A IL 16576304A IL 16576304 A IL16576304 A IL 16576304A IL 165763 A0 IL165763 A0 IL 165763A0
Authority
IL
Israel
Prior art keywords
sub
oxazol
preparing
benzoic acid
acid derivatives
Prior art date
Application number
IL16576304A
Other languages
English (en)
Original Assignee
Pharmacia & Upjohn Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Ltd filed Critical Pharmacia & Upjohn Co Ltd
Publication of IL165763A0 publication Critical patent/IL165763A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
IL16576304A 2002-06-20 2004-12-14 Process for preparing 5-(1,3-oxazol-2-yl)benzoic acid derivatives IL165763A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028502P 2002-06-20 2002-06-20
US45047803P 2003-02-27 2003-02-27
PCT/US2003/019585 WO2004000821A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives

Publications (1)

Publication Number Publication Date
IL165763A0 true IL165763A0 (en) 2006-01-15

Family

ID=30003150

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16576304A IL165763A0 (en) 2002-06-20 2004-12-14 Process for preparing 5-(1,3-oxazol-2-yl)benzoic acid derivatives

Country Status (17)

Country Link
US (2) US7115747B2 (enExample)
EP (1) EP1532123B1 (enExample)
JP (1) JP2005533811A (enExample)
CN (1) CN1324017C (enExample)
AT (1) ATE370131T1 (enExample)
AU (1) AU2003249344A1 (enExample)
BR (1) BR0312439A (enExample)
CA (1) CA2489988A1 (enExample)
CO (1) CO5670350A2 (enExample)
DE (1) DE60315664D1 (enExample)
EA (1) EA008389B1 (enExample)
IL (1) IL165763A0 (enExample)
MX (1) MXPA04012630A (enExample)
NO (1) NO20045497L (enExample)
NZ (1) NZ537390A (enExample)
PL (1) PL374999A1 (enExample)
WO (1) WO2004000821A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0316629A (pt) * 2002-11-27 2005-10-11 Elan Pharm Inc Uréias e carbamatos substituìdos
TW200738701A (en) * 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
US7872009B2 (en) * 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
US7838676B2 (en) * 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
US7745484B2 (en) 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
EP1971598A1 (en) 2005-11-21 2008-09-24 Amgen Inc. Beta-secretase modulators and methods of use
WO2008137954A2 (en) * 2007-05-07 2008-11-13 Environmental Packaging Technologies Limited Universal shipping container
US8163909B2 (en) 2007-05-25 2012-04-24 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
JP5440984B2 (ja) * 2007-05-25 2014-03-12 アムジエン・インコーポレーテツド β−セクレターゼ修飾剤としての置換ヒドロキシエチルアミン化合物および使用方法
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
KR20110073511A (ko) 2008-09-11 2011-06-29 암젠 인크 베타세크레타제 조절제로서의 스피로-테트라사이클릭 고리 화합물 및 사용 방법
WO2011063233A1 (en) 2009-11-23 2011-05-26 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
EP2504330A1 (en) 2009-11-23 2012-10-03 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
CA2788363A1 (en) 2010-01-19 2011-07-28 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
JP5584352B2 (ja) 2010-03-15 2014-09-03 アムジエン・インコーポレーテツド β−セクレターゼ調節剤としてのアミノ−ジヒドロオキサジン系およびアミノ−ジヒドロチアジン系スピロ化合物ならびにそれらの医学的用途
CA2791281A1 (en) 2010-03-15 2011-09-22 Amgen Inc. Spiro-tetracyclic ring compounds as beta-secretase modulators
EP2673279A1 (en) 2011-02-07 2013-12-18 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use
EP2758406A1 (en) 2011-09-21 2014-07-30 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9725469B2 (en) 2012-11-15 2017-08-08 Amgen, Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US11272751B2 (en) 2016-03-01 2022-03-15 Nicholas Popejoy Protective headgear, impact diffusing systems and methods
US9462841B1 (en) 2016-03-01 2016-10-11 William Popejoy Protective headgear and shoulder pad apparatus and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020276A1 (es) * 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
CA2462851A1 (en) 2001-10-04 2003-04-10 Elan Pharmaceuticals, Inc. Hydroxypropylamines
AR039555A1 (es) * 2001-11-08 2005-02-23 Upjohn Co Derivados n,n'-sustituidos de 1,3-diamino-2-hidroxipropano
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
DE60315664D1 (de) 2007-09-27
CN1324017C (zh) 2007-07-04
EP1532123A1 (en) 2005-05-25
NO20045497D0 (no) 2004-12-16
NO20045497L (no) 2005-03-07
PL374999A1 (en) 2005-11-14
EA008389B1 (ru) 2007-04-27
CN1662510A (zh) 2005-08-31
MXPA04012630A (es) 2005-09-30
BR0312439A (pt) 2005-05-10
EP1532123B1 (en) 2007-08-15
AU2003249344A1 (en) 2004-01-06
US20070105921A1 (en) 2007-05-10
NZ537390A (en) 2006-07-28
JP2005533811A (ja) 2005-11-10
CO5670350A2 (es) 2006-08-31
CA2489988A1 (en) 2003-12-31
HK1081543A1 (zh) 2006-05-19
ATE370131T1 (de) 2007-09-15
US7115747B2 (en) 2006-10-03
EA200401510A1 (ru) 2005-06-30
WO2004000821A1 (en) 2003-12-31
US20040063965A1 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
IL165763A0 (en) Process for preparing 5-(1,3-oxazol-2-yl)benzoic acid derivatives
MXPA05011150A (es) 2-hidroxi-3-diaminoalcanos de benzamida.
TW200510405A (en) Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
EA200101194A1 (ru) Производные 4,5,6,7-тетрагидроиндазола в качестве противоопухолевых средств
CA2665931C (en) Hydrobenzamide derivatives as inhibitors of hsp90
GB0318447D0 (en) Therapeutic agents
JO2282B1 (en) Oxazole derivatives
GB0318343D0 (en) No title
MXPA05012415A (es) Inhibidores de glutamina fructosa-3-fosfato amidotransferasa (gfat).
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
EA200500006A1 (ru) Лекарственное средство для лечения нейродегенеративных заболеваний
PL1685142T3 (pl) Pochodne kwasu fosfinowego, inhibitory beta-sekterazy do leczenia choroby Alzheimera
PT1989174E (pt) Derivados de ciclo-hexilmetilo substituídos
AU2003242144A1 (en) Processes for producing epoxytriazole derivative and intermediate therefor
PT1709027E (pt) Compostos do tipo hidrazida e sua utilização em composições farmacêuticas para o tratamento de doenças cardiovasculares
EP1036793A3 (en) A process for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative
ATE496907T1 (de) Verfahren zur herstellung von cilostazol
TW200621685A (en) Hydroxynaphthoic acid hydrazide compound and method for preparing the same
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
NO20033049D0 (no) Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1
MXPA05009122A (es) Derivados de acido benzoilureidopiridil-piperidin-y pirrolidin-carboxilico sustituido, metodo para su produccion y su uso.
MXPA05013732A (es) Proceso para preparacion de sensibilizador de insulina y compuesto intermediario del mismo.
WO2004067505A3 (en) Bismuth dithiocarbamate compounds and uses thereof
TW200612912A (en) Benzyloxy derivatives as maob inhibitors